Vascular Endothelial Growth Factor Receptor 2 Controls Blood Pressure by Regulating Nitric Oxide Synthase Expression-Reference-Cited by-同舟云学术

Vascular Endothelial Growth Factor Receptor 2 Controls Blood Pressure by Regulating Nitric Oxide Synthase Expression

Published:2009-09 Issue:3 Volume:54 Page:652-658
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Facemire Carie S.¹,Nixon Andrew B.¹,Griffiths Robert¹,Hurwitz Herbert¹,Coffman Thomas M.¹

Affiliation:

1. From the Divisions of Nephrology (C.S.F., R.G., T.M.C.) and Medical Oncology (A.B.N., H.H.), Department of Medicine, Duke University and Durham Veterans’ Affairs Medical Centers, Durham, NC.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference39 articles.

1. Vascular Endothelial Growth Factor: Basic Science and Clinical Progress

2. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis.

3. The VIVA Trial

Cited by 243 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The antihypertensive effect of Alizarin is achieved by activating VEGFR2/eNOS pathway, attenuating oxidative stress-induced mitochondrial damage and premature senescence;Life Sciences;2024-08

2. Macrophages preserve endothelial cell specialization in the adrenal gland to modulate aldosterone secretion and blood pressure;Cell Reports;2024-07

3. The efficacy and safety of cabozantinib in patients with metastatic or advanced renal cell carcinoma: a systematic review and meta-analysis;Baylor University Medical Center Proceedings;2024-06-17

4. Comparative efficacy and safety of cabozantinib for malignant tumors: a systematic review and meta-analysis;Expert Review of Anticancer Therapy;2024-04

5. Impact of Hypertension in Cancer Patients Treated With Anti-Vascular Endothelial Growth Factor Therapy;Circulation Journal;2024-01-25